Product image of Caprelsa (Vandetanib) supplied by GNH India

Caprelsa

Active Ingredient:
Vandetanib
Origin:
EU

Caprelsa (Vandetanib)

Caprelsa (Vandetanib) is an oral medication used to manage certain types of cancer. This drug is designed to target specific receptors involved in cancer cell growth, offering a targeted approach to treatment.

Manufacturer / TM Owner

Sanofi B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Caprelsa is primarily used in the treatment of advanced medullary thyroid cancer. It works by inhibiting the activity of specific receptors that play a role in cancer cell proliferation. Patients often wonder, 'What is Caprelsa used for?' This medication is intended for those who have progressive or symptomatic medullary thyroid cancer.

Side Effects

  • Common effects of Caprelsa may include fatigue, diarrhea, and skin rash. Some users also report appetite loss and nausea. These effects can vary in intensity and duration among individuals. It's important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Precautions & Warnings

  • Caprelsa should be handled with care, especially by those with a history of heart conditions or electrolyte imbalances. Regular monitoring of heart function and electrolyte levels is recommended. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider before starting this medication.

Avoid Interactions

  • Caprelsa may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It's advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of this drug. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Caprelsa is used to treat advanced medullary thyroid cancer by targeting specific receptors involved in cancer cell growth.

Caprelsa is taken orally, typically once daily. Follow the instructions provided by your healthcare provider for the best results.

Common side effects include fatigue, diarrhea, skin rash, appetite loss, and nausea. These effects can vary among individuals.

Caprelsa may interact with certain medications, especially those metabolized by the liver's CYP3A4 enzyme. Always consult your healthcare provider before combining medications.

Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider before starting Caprelsa.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Vandetanib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT